May 7, 2024
James Helzberg
Share
Article Link: https://pubmed.ncbi.nlm.nih.gov/36626622/
What regimens are most effective for induction and maintenance therapy for patients with autoimmune hepatitis?
April 1, 2022
Phase 3 Trial of Resmetirom in MASH with Liver Fibrosis
July 3, 2024
Can Larsucosterol Be Used to Treat Acute Alcohol-Associated Hepatitis?
June 3, 2024